LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 1209 | 1594 | 4203 | 0.3800 | 0.1664 |
MCF7 | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1390 | 4203 | 0.3315 | 0.0809 |
MCF7 | Neratinib | 10 | uM | LJP5 | 72 | hr | 1209 | 1377 | 4203 | 0.3283 | 0.0751 |
MCF7 | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1209 | 2904 | 4012 | 0.7236 | 0.6583 |
MCF7 | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 1209 | 2618 | 4012 | 0.6523 | 0.5618 |
MCF7 | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 1209 | 2084 | 4012 | 0.5201 | 0.3704 |
MCF7 | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 1209 | 1633 | 4012 | 0.4082 | 0.1901 |
MCF7 | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1326 | 4012 | 0.3306 | 0.0542 |
MCF7 | JW-7-24-1 | 10 | uM | LJP6 | 72 | hr | 1209 | 937 | 4012 | 0.2339 | -0.1376 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 3206 | 4203 | 0.7621 | 0.7182 |
MCF7 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1209 | 1642 | 4012 | 0.4094 | 0.1929 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 2258 | 4203 | 0.5386 | 0.4170 |
MCF7 | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 1209 | 1521 | 4012 | 0.3786 | 0.1395 |
MCF7 | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1636 | 4203 | 0.3904 | 0.1839 |
MCF7 | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 1209 | 1671 | 4012 | 0.4174 | 0.2064 |
MCF7 | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 1209 | 1495 | 4203 | 0.3557 | 0.1241 |
MCF7 | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 1209 | 1591 | 4012 | 0.3971 | 0.1721 |
MCF7 | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 1209 | 1616 | 4203 | 0.3852 | 0.1753 |
MCF7 | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 1209 | 1545 | 4012 | 0.3848 | 0.1507 |
MCF7 | Dasatinib | 10 | uM | LJP5 | 72 | hr | 1209 | 1660 | 4203 | 0.3954 | 0.1920 |
MCF7 | Dasatinib | 10 | uM | LJP6 | 72 | hr | 1209 | 1231 | 4012 | 0.3069 | 0.0089 |
MCF7 | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 1209 | 1353 | 4203 | 0.3225 | 0.0646 |
MCF7 | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 1209 | 1412 | 4203 | 0.3362 | 0.0895 |
MCF7 | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 1209 | 1406 | 4203 | 0.3343 | 0.0857 |
MCF7 | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 1209 | 1441 | 4203 | 0.3433 | 0.1021 |